Accuryn gives your team continuous fluid data, predictive kidney alerts, and the only continuous real-time intra-abdominal pressure monitoring platform. One platform. One catheter. No blind spots.
Cleared
U.S. Hospitals
and Published
Award
Hospitals have real-time monitoring for nearly every organ. The kidneys are the exception.
Fluid outputs are still measured with a gravity-fed catheter designed in 1933. The data is late, often wrong, and leaves clinical teams managing therapy with incomplete information.
By the time the blood test catches up, the window to protect the kidney has closed. That damage may be irreversible.
CMS now classifies AKI as a hospital-acquired harm.
Added cost per stage 3 AKI patient
Additional length of stay at stage 2
Likely to require dialysis at stage 2
One platform that takes kidney management from highly variable to highly reliable.
A continuous monitoring system that gives your team accurate fluid data, predictive kidney alerts, and real-time intra-abdominal pressure.
Two components: the SmartFoley catheter and the Accuryn Monitor.
The patented SmartFoley® maintains catheter patency automatically no milking, no dependent loop errors, no manual nursing intervention. It eliminates retained urine (the 96ml problem) and removes catheter manipulation from the CAUTI equation entirely.
Continuous urine output tracking. Intra-abdominal pressure updated 100× per second. Bladder temperature. AKI alerts based on KDIGO criteria. Trend visualization that shows kidney response to therapy in real time — so you can adjust treatment based on what’s happening now, not what happened at the last lab draw.
Actively cleared urine output data. Continuous IAP trending. KDIGO-based kidney distress alerts.
Traditional catheters measure urine at the edge of the bed. Anything stuck between there and the bladder goes unmeasured.
Accuryn’s patented Active Drain Line Clearance continuously sweeps the entire line. No retained urine. No manual milking. No wrong numbers.
The result: One burn ICU recorded 450+ consecutive days with zero catheter-associated infections. 2,243 patients, a 10x CAUTI reduction (P<0.01).
Brockway et al., Life 2022. SCCM STAR Research Award.
Most hospitals measure intra-abdominal pressure once per stay, if at all. It requires a separate invasive procedure, so it rarely gets done.
Accuryn measures it continuously. Every patient gets their own pressure trend line. No additional procedure. No additional cost.
A Premier GPO evaluated Accuryn across ~6,000 member hospitals and identified continuous IAP as its single most significant differentiator. Emerging peer-reviewed evidence suggests IAP should be the sixth vital sign.
In one published case, continuous IAP trending identified occult internal bleeding invisible to any other measure.
Premier GPO evaluation across ~6,000 member hospitals.
Serum creatinine was never designed to be an early warning. The kidneys can lose more than half their filtering capacity before creatinine rises.
Accuryn applies KDIGO criteria to continuous urine output data and alerts your team to kidney distress while there is still time to intervene.
In a study of 522 cardiac surgery patients, Accuryn detected Stage 2 AKI an average of 33.6 hours before serum creatinine.
Journal of Cardiothoracic and Vascular Anesthesia, 2024.
Actively cleared urine output data. Continuous IAP trending. KDIGO-based kidney distress alerts.
70+ U.S. Hospitals · 6 Children's Hospitals · 19 Teaching Hospitals · 13 VA / DoD Facilities
Data integrates directly into your EMR flow sheet. No separate system.
Kidney data where your clinicians already work.
SmartFoley inserts using the same technique as a standard Foley. No new training. No learning curve. Your team already knows how.
The Accuryn Monitor is operational in minutes. Clinical utility starts immediately, even before flow sheet integration.
Continuous data. Automated alerts. Real-time IAP trending. Your team sees problems developing, not problems that already happened.
Hospitals building their baseline now will have years of data. Hospitals that start now will have years of baseline data before reporting begins.
But the real clock is the one running on every catheterized patient in your unit right now. Without continuous monitoring, kidney distress is invisible until the damage is done.
Urine meters measure output. Accuryn is a kidney management platform with patented drain line clearance, continuous IAP, and predictive KDIGO alerts. No other system has all three.
SmartFoley places like a standard Foley. The monitor sets up in minutes. Most teams are live within days, not months. Flow sheet integration is available but not required to start.
Accuryn removes work. Automated measurement replaces hourly manual reads. Drain line clearance eliminates catheter milking. Accurate data removes the friction when output numbers get questioned.
A single AKI escalation to Stage 3 adds $25K to $40K+ in costs. Add CAUTI prevention, reduced nursing burden, and CMS compliance. ROI builds across multiple line items.
Wherever fluid status matters: surgical ICU, cardiac surgery, burn, trauma, pediatric, postpartum. One health system deployed across every unit.
Multiple peer-reviewed studies. 33.6-hour earlier AKI detection (JCTVA 2024). 10x CAUTI reduction over 8 years (Life 2022, SCCM STAR Award). Published IAP case reports.
Our clinical specialists demo Accuryn at the bedside. In your unit, with your
team, on your workflow.
Not ready to talk? Download the Research Compendium — every published study on AKI detection, CAUTI reduction, and clinical outcomes. Built for your quality committee.
Start with one unit. See the data in your own patients.